The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset
Open accessAbstract
The efficacy of thalidomide (α-phthalimido-glutarimide) therapy in leprosy patients with erythema nodosum leprosum is thought to be due to inhibition of tumor necrosis factor α. In other diseases reported to respond to thalidomide, the mechanism of action of the drug is unclear. We show that thalidomide is a potent costimulator of primary human T cells in vitro, synergizing with stimulation via the T cell receptor complex to increase interleukin 2–mediated T cell proliferation and interferon γ production. The costimulatory effect is greater on the CD8+ than the CD4+ T cell subset. The drug also increases the primary CD8+ cytotoxic T cell response induced by allogeneic dendritic cells in the absence of CD4+ T cells. Therefore, human T cell costimulation can be achieved pharmacologically with thalidomide, and preferentially in the CD8+ T cell subset.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., & Kaplan, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.699 · Cited by 1,192
Self-citationImmunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
Bender, A., Sapp, M., Schuler, G., Steinman, R. M., & Bhardwaj, N. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00079-8 · Cited by 663
Thalidomide in the treatment of lepra reactions
Sheskin, J. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563303 · Cited by 533
Jacobson, J. M., Greenspan, J. S., Spritzler, J., Ketter, N., Fahey, J. L., Jackson, J. B., Fox, L., Chernoff, M., Wu, A. W., MacPhail, L. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362103 · Cited by 420
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease
Stack, W., Mann, S., Roy, A., Heath, P., Sopwith, M., Freeman, J., Holmes, G., Long, R., Forbes, A., Kamm, M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80083-9 · Cited by 384
Sampaio, E. P., Kaplan, G., Miranda, A., Nery, J. A. C., Miguel, C. P., Viana, S. M., & Sarno, E. N. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.408 · Cited by 366
Self-citationLess Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8 -/- Mice
Koh, D.-R., Fung-Leung, W.-P., Ho, A., Gray, D., Acha-Orbea, H., & Mak, T.-W. (1992) · Science · doi:10.1126/science.256.5060.1210 · Cited by 352
Mchugh, S. M., Rifkin, I. R., Deighton, J., Wilson, A. B., Lachmann, P. J., Lockwood, C. M., & Ewan, P. W. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05527.x · Cited by 263
Jenkins, M. K., Ashwell, J. D., & Schwartz, R. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3324 · Cited by 258
Mayer, L., & Eisenhardt, D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114832 · Cited by 202
Chen, T., Vogelsang, G. B., Petty, B. G., Brundrett, R. B., Noe, D. A., Santos, G. W., & Colvin, O. M. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07646-9 · Cited by 122
Thalidomide in Crohn's disease
Wettstein, A. R., Meagher, A. P., & Meagher, A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64206-7 · Cited by 96
Haslett, P. A. J., Hempstead, M., Seidman, C. E., Diakun, J., Vasquez, D., Freedman, V. H., & Kaplan, G. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1047 · Cited by 89
Self-citationWare, R., Jiang, H., Braunstein, N. S., Kent, J. R., Wiener, E., Pernis, B., & Chess, L. (1995) · Immunity · doi:10.1016/s1074-7613(95)80066-2 · Cited by 63
An Internally-controlled Double Blind Trial of Thalidomide in Severe Erythema Nodosum Leprosum
WATERS, M. F. R. (1971) · Leprosy Review · doi:10.5935/0305-7518.19710004 · Cited by 63
Rj, K., Eiras, G., Burckart, G. J., Rs, S., HARDESTY, R. L., Vogelsang, G. B., GRIFFITH, B. P., & ZEEVI, A. (1991) · Transplantation · doi:10.1097/00007890-199111000-00029 · Cited by 50
Effect of Thalidomide on the Graft versus Host Reaction
Field, E. O., Gibbs, J. E., Tucker, D. F., & Hellmann, K. (1966) · Nature · doi:10.1038/2111308a0 · Cited by 47
Keenan, R. J., Eiras, G., Burckart, G. J., et al. (1991) · PubMed · Cited by 45
McCarthy, D., Kanfer, E., & Barrett, A. J. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90089-9 · Cited by 27
Cited by
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
Davies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F. E., Tai, Y.-T., Treon, S. P., Lin, B., Schlossman, R. L., Richardson, P., et al. (2000) · Blood · doi:10.1182/blood.v96.9.2943 · Cited by 875
The evolution of thalidomide and its IMiD derivatives as anticancer agents
Bartlett, J. B., Dredge, K., & Dalgleish, A. G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1323 · Cited by 809
Metadata
- Authors
- Haslett, P. A. J., Corral, L. G., Albert, M., & Kaplan, G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-06-01
- Volume
- 187
- Issue
- 11
- Pages
- 1885-1892
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2125559109
- Cited by
- 573
- References
- 22
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.